Background: Urotensin-II (U-II) is a short cyclic peptide that is widely recognized as one of
the most potent vasoconstrictors. U-II plays a role in the pathophysiology of MS, participating …

Up to date, human urotensin II (UII) is the most potent vasoconstrictor in mammalian
animals. To explore whether UII played an important role in the development of …

J Clin Hypertens (Greenwich). 2010; 12: 653–660.© 2010 Wiley Periodicals, Inc. Urotensin II
(UII) exerts multiple effects on the cardiovascular system, acts as a diabetogenic agent, and …

Urotensin II (UII) is a vasoactive peptide that was first discovered in the teleost fish, and later
in mammals and humans. UII binds to the G protein coupled receptor GPR14 (now known as …

Urotensin II (UII) has been found to be a potent vasoactive peptide in humans and in a
number of relevant animal models of cardiovascular disease such as the mouse, rat and …

Urotensin II is a potent vasoconstrictive peptide that mediates both endothelium-
independent vasoconstriction and endothelium-dependent vasodilatation. Its plasma level …

Abstract Background Increased plasma Urotensin II (UII) levels have been found in adults
with renal diseases. Studies in children are scarce. The objective of the study is to estimate …

Human urotensin II (U-II), the most potent vasoconstrictor peptide identified to date, and its
receptor (UT) are involved in atherosclerosis. U-II is expressed in endothelial cells …

Urotensin II (UII) is an 11 amino acid cyclic peptide originally isolated from the goby fish. The
amino acid sequence of UII is exceptionally conserved across most vertebrate taxa, sharing …

Objective We aimed to evaluate the controversial association between human urotensin II
and essential hypertension in untreated hypertensive cases and normotensive controls …